PremiumRatingsAstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target8h agoAZN
AstraZeneca: Strong Pipeline and Growth Outlook Support Buy Rating and Unchanged 16,500 GBp Price Target
PremiumCompany AnnouncementsAstraZeneca invests $2bn in Summit to accelerate bispecific and ADC cancer portfolio9h agoAZN